Skip to main content
. 2022 Aug 31;24(4):366. doi: 10.3892/ol.2022.13486

Figure 2.

Figure 2.

Network of the available direct comparisons in the included studies. SorCDDP, sorafenib with cisplatin-HAIC; PF-HAIC, 5-fluorouracil-based HAIC; TACE, transcatheter arterial chemoembolization; HAIC, hepatic artery infusion chemotherapy.